Campi C, Escovich L,
Moreno A, Racca L, Racca A, Cotorruelo C, Biondi C. Expression of the gene encoding secretor type galactoside 2 α fucosyltransferase
(FUT2) and ABH antigens in patients with oral lesions. Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e63-8.
doi:10.4317/medoral.17239
1. Clausen H, Bennett EP, Grunnet
N. Molecular genetics of ABO histo-blood groups. Transfus Clin Biol. 1994;1:79-89.
http://dx.doi.org/10.1016/S1246-7820(94)80001-4
2. Ravn V, Dabelsteen
E. Tissue distribution of histo-blood group antigens.
APMIS. 2000;108:1-28.
http://dx.doi.org/10.1034/j.1600-0463.2000.d01-1.x
PMid:10698081
3. Wang B, Akiyama K, Jia JT, Kimura H. Measuring H
type 1 and H type 2 antigens in human saliva by immunoassay using artificial
antigens as standard substances. Forensic Sci Int.
1994;67:1-8.
http://dx.doi.org/10.1016/0379-0738(94)90405-7
4. Daniels G. Functions of red cell surface proteins. Vox Sang. 2007;93:331-40.
PMid:18070278
5. Orntoft TF, Holmes EH, Johnson P, Hakomori S, Clausen H. Differential tissue expression of
the Lewis blood group antigens: enzymatic, immunohistologic,
and immunochemical evidence for Lewis a and b antigen expression in Le(a-b-)
individuals. Blood. 1991;77:1389-96.
PMid:2001461
6. Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H.
Ancient origin of the null allele se(428) of the human ABO-secretor locus
(FUT2). J Mol Evol. 2000;50:243-8.
PMid:10754067
7. Koda Y, Soejima M,
Kimura H. The polymorphisms of fucosyltransferases.
Leg Med (Tokyo). 2001;3:2-14.
http://dx.doi.org/10.1016/S1344-6223(01)00005-0
8. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clément M. ABH and Lewis histo-blood
group antigens in cancer. APMIS. 2001;109:9-31.
http://dx.doi.org/10.1111/j.1600-0463.2001.tb00011.x
PMid:11297197
9. Hakomori S. Antigen structure and genetic basis of
histo-blood groups A, B and O: their changes
associated with human cancer. Biochim Biophys Acta.
1999;1473:247-66.
http://dx.doi.org/10.1016/S0304-4165(99)00183-X
10. Dabelsteen E, Roed-Petersen B, Pindbrog JJ. Loss of epithelial blood group antigens A and B in oral
premalignant lesions. Acta Pathol
Microbiol Scand A. 1975;83:292-300.
11. Hakomori S. Glycosylation
defining cancer malignancy: new wine in an old bottle. Proc Natl
Acad Sci U S A. 2002;99:10231-3.
http://dx.doi.org/10.1073/pnas.172380699
PMid:12149519 PMCid:124893
12. Dabelsteen E, Clausen H, Holmstrup
P, Reibel J. Premalignant and malignant oral lesions
are associated with changes in the glycosylation
pattern of carbohydrates related to ABH blood group antigens. APMIS. 1988;96:813-9.
http://dx.doi.org/10.1111/j.1699-0463.1988.tb00948.x
PMid:3048339
13. Gao S, Worm J, Guldberg
P, Eiberg H, Krogdahl A,
Liu CJ, et al. Genetic and epigenetic alterations of the blood group ABO gene
in oral squamous cell carcinoma. Int J Cancer.
2004;109:230-7.
http://dx.doi.org/10.1002/ijc.11592
PMid:14750174
14. Campi C, Escovich L,
Valdés V, García Borrás S, Racca
L, Racca A, et al. Secretor
status and ABH antigens expression in patients with oral lesions. Med Oral Patol Oral Cir
Bucal. 2007;12:E431-4.
PMid:17909508
15. López-Ferrer A, de Bolós C, Barranco C, Garrido
M, Isern J, Carlstedt I, et
al. Role of fucosyl-transferases
in the association between apomucin and Lewis antigen
expression in normal and malignant gastric epithelium. Gut. 2000;47:349-56.
http://dx.doi.org/10.1136/gut.47.3.349
PMid:10940270 PMCid:1728024
16. Dabelsteen E, Gao S. ABO blood-group antigens in oral cancer. J
Dent Res. 2005;84:21-8.
http://dx.doi.org/10.1177/154405910508400103
PMid:15615870
17. Hakomori S. Structure, organization, and function of glycosphingolipids
in membrane. Curr Opin Hematol.
2003;10:16-24.
http://dx.doi.org/10.1097/00062752-200301000-00004
PMid:12483107
18. Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, et
al. Molecular genetic analysis of the human Lewis histo-blood
group system. J Biol Chem. 1994;269:29271-8.
PMid:7961897
19. Strauchen JA, Bergman SM, Hanson TA. Expression of A and B tissue isoantigens
in benign and malignant lesions of the breast. Cancer.
1980;45:2149-55.
http://dx.doi.org/10.1002/1097-0142(19800415)45:8<2149::AID-CNCR2820450823>3.0.CO;2-7
20. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature.
1990;345:229-33.
http://dx.doi.org/10.1038/345229a0
PMid:2333095
21. Henry S, Oriol R, Samuelsson B. Lewis histo-blood group system and associated secretory
phenotypes. Vox Sang. 1995;69:166-82.
http://dx.doi.org/10.1111/j.1423-0410.1995.tb02591.x
PMid:8578728
22. Foresto P, Biondi C, Brufman
A, Yaber F, Yaber F, Solis E, et al. Deletion of ABH antigens in
urine sediment cells from patients with prostatic adenoma. Arch Esp Urol. 2000;53:770-3.
PMid:11196383
23. Santos-García A, Abad-Hernández
MM, Fonseca-Sánchez E, Cruz-Hernández
JJ, Bullón-Sopelana A. Proteic
expression of p53 and cellular proliferation in oral leukoplakias.
Med Oral Patol Oral Cir Bucal. 2005;10:5-8, 1-5.
24. Gao S, Bennett EP, Reibel
J, Chen X, Christensen ME, Krogdahl A, et al. Histo-blood group ABO antigen in oral potentially malignant
lesions and squamous cell carcinoma--genotypic and
phenotypic characterization. APMIS. 2004;112:11-20.
http://dx.doi.org/10.1111/j.1600-0463.2004.apm1120103.x
PMid:14961969